---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011140"
form_type: "8-K"
ticker: "TGTX"
cik: "0001001316"
company_name: "TG THERAPEUTICS, INC."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-13T23:32:16.470190+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TG Therapeutics shareholders reject say-on-pay and share increase at annual meeting

## Summary
- Advisory say-on-pay failed: 26.0M For (37.4%) vs 43.5M Against (62.6%).
- Proposal to increase authorized shares from 175M to 200M failed; 69.9M For but not majority of outstanding 149.4M shares.
- Only directors Michael Weiss (75.8%) and Laurence Charney (66.1%) received majority for; others <60%.
- Ratification of KPMG as auditor approved with 102.3M For (99.8% of votes cast).

## SEC filing metadata
- accession: 0001558370-23-011140
- form_type: 8-K
- ticker: TGTX
- cik: 0001001316
- company_name: TG THERAPEUTICS, INC.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/0001558370-23-011140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001316/000155837023011140/tgtx-20230614x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011140
- JSON: https://secwatch.observer/filing/0001558370-23-011140.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.